KaloBios Presents Clinical Results with Anti-GM-CSF Antibody in Persistent Asthma Data from KB002 Phase 1/2 Study Presented at the American Academy of Allergy, Asthma and Immunology Meeting

February 26, 2013

Source: Humanigen, Inc.

Released February 26, 2013

©2019 Humanigen, Inc.  All rights reserved